CrkL is a co-activator of estrogen receptor alpha that enhances tumorigenic potential in cancer.
about
Potential cancer-related role of circadian gene TIMELESS suggested by expression profiling and in vitro analysesGenome wide proteomics of ERBB2 and EGFR and other oncogenic pathways in inflammatory breast cancer.A mouse splice-site mutant and individuals with atypical chromosome 22q11.2 deletions demonstrate the crucial role for crkl in craniofacial and pharyngeal development.The role of CT10 regulation of kinase-like in cancer.Estrogen-Initiated Protein Interactomes During Embryo Implantation.
P2860
CrkL is a co-activator of estrogen receptor alpha that enhances tumorigenic potential in cancer.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
CrkL is a co-activator of estr ...... morigenic potential in cancer.
@ast
CrkL is a co-activator of estr ...... morigenic potential in cancer.
@en
type
label
CrkL is a co-activator of estr ...... morigenic potential in cancer.
@ast
CrkL is a co-activator of estr ...... morigenic potential in cancer.
@en
prefLabel
CrkL is a co-activator of estr ...... morigenic potential in cancer.
@ast
CrkL is a co-activator of estr ...... morigenic potential in cancer.
@en
P2093
P2860
P356
P1476
CrkL is a co-activator of estr ...... umorigenic potential in cancer
@en
P2093
Lini Nirmala
Malini Laloraya
Renjini Ambika Padmanabhan
P2860
P304
P356
10.1210/ME.2011-0008
P50
P577
2011-06-23T00:00:00Z